| BP0083-50MG
| InVivoPlus mouse IgG1 isotype control, unknown specificity
| 50 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0063-25MG
| InVivoPlus anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0051-5MG
| InVivoPlus anti-mouse IL-12 p40
| 5 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0079-25MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 25 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0398-100MG
| InVivoMAb anti-mouse CD83
| 100 mg
| BioXCell
| in vivo CD83 engagement, in vitro CD83 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0146-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0213-5MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 5 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF1R neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-100MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 100 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0394-5MG
| InVivoMAb anti-mouse IL-25
| 5 mg
| BioXCell
| in vivo IL-25 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0411-25MG
| InVivoMAb anti-human GC1q R (C1QBP)
| 25 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0414-25MG
| InVivoMAb anti-rat TCR ?/?
| 25 mg
| BioXCell
| in vivo ?/? T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0079-5MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 5 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0307-100MG
| InVivoPlus anti-mouse CD16/CD32
| 100 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0036-5MG
| InVivoPlus anti-mouse NK1.1
| 5 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0413-1MG
| InVivoMAb anti-rat TCR ?/?
| 1 mg
| BioXCell
| in vivo administration
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0301-5MG
| InVivoPlus human IgG2 isotype control
| 5 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BP0087-100MG
| InVivoPlus polyclonal Syrian hamster IgG
| 100 mg
| BioXCell
|
|
| Syrian Hamster
|
| Solicitar Precio
| Solicitar
|
| BP0101-5MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 5 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0290-25MG
| InVivoPlus rat IgG1 isotype control, anti-trinitrophenol
| 25 mg
| BioXCell
|
|
| Rat
| Rat
| Solicitar Precio
| Solicitar
|
| BP0169-50MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 50 mg
| BioXCell
| in vivo activation of 4-1BB
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0404-5MG
| InVivoMAb anti-human GPC3
| 5 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0383-5MG
| InVivoMAb anti-mouse/human/rat PD-L1
| 5 mg
| BioXCell
| in vivo PD-L1 blockade
, in vitro PD-L1 blockade
,
|
| Mouse/Human/Rat
|
| Solicitar Precio
| Solicitar
|
| BP0066-5MG
| InVivoPlus anti-mouse Thy1.2 (CD90.2)
| 5 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0057-5MG
| InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 5 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| Goat, Dog, Hamster, Human, Monkey, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BP0089-100MG
| InVivoPlus rat IgG2a isotype control, anti-trinitrophenol
| 100 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0400-5MG
| InVivoMAb anti-mouse RGMb
| 5 mg
| BioXCell
| in vivo RGMb blockade, ELISA, Flow cytometry, ,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0017-1-25MG
| InVivoPlus anti-mouse CD40L (CD154)
| 25 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0380-1MG
| InVivoMAb anti-human c-Kit (CD117)
| 1 mg
| BioXCell
| in vivo c-Kit+ cell depletion, in vitro c-Kit targ
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0409-5MG
| InVivoMAb anti-human BRCA1
| 5 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0310-50MG
| InVivoPlus anti-mouse VISTA
| 50 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0411-1MG
| InVivoMAb anti-human GC1q R (C1QBP)
| 1 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0058-25MG
| InVivoPlus anti-mouse TNF?
| 25 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0146-5MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0390-50MG
| InVivoMAb anti-canine PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Wester
|
| Dog
| Dog
| Solicitar Precio
| Solicitar
|
| BE0409-1MG
| InVivoMAb anti-human BRCA1
| 1 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0283-5MG
| InVivoPlus anti-mouse/human/rat CD47 (IAP)
| 5 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blocking, Imm
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0411-5MG
| InVivoMAb anti-human GC1q R (C1QBP)
| 5 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0055-25MG
| InVivoPlus anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0391-5MG
| InVivoMAb anti-human MUC16
| 5 mg
| BioXCell
| Flow cytometry, Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0050-50MG
| InVivoPlus anti-mouse IL-10R (CD210)
| 50 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0310-100MG
| InVivoPlus anti-mouse VISTA
| 100 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0090-100MG
| InVivoPlus rat IgG2b isotype control, anti-keyhole limpet hemocyanin
| 100 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BP0045-25MG
| InVivoPlus anti-mouse IL-4
| 25 mg
| BioXCell
| in vivo IL-4 neutralization, in vitro IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0410-50MG
| InVivoMAb anti-human EphA2
| 50 mg
| BioXCell
|
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0401-100MG
| InVivoMAb anti-human CEACAM5
| 100 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0387-50MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 50 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0404-25MG
| InVivoMAb anti-human GPC3
| 25 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0075-5MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 5 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0031-50MG
| InVivoPlus anti-mouse OX40 (CD134)
| 50 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0050-25MG
| InVivoPlus anti-mouse IL-10R (CD210)
| 25 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|